Alpha Teknova (TKNO) Competitors $4.36 +0.12 (+2.83%) Closing price 04:00 PM EasternExtended Trading$4.36 0.00 (0.00%) As of 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TKNO vs. CRON, NUVB, VERV, VALN, MLYS, ATAI, IOVA, UPB, ORIC, and PHARShould you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Cronos Group (CRON), Nuvation Bio (NUVB), Verve Therapeutics (VERV), Valneva (VALN), Mineralys Therapeutics (MLYS), atai Life Sciences (ATAI), Iovance Biotherapeutics (IOVA), Upstream Bio (UPB), Oric Pharmaceuticals (ORIC), and Pharming Group (PHAR). These companies are all part of the "pharmaceutical products" industry. Alpha Teknova vs. Its Competitors Cronos Group Nuvation Bio Verve Therapeutics Valneva Mineralys Therapeutics atai Life Sciences Iovance Biotherapeutics Upstream Bio Oric Pharmaceuticals Pharming Group Cronos Group (NASDAQ:CRON) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation. Which has better earnings and valuation, CRON or TKNO? Cronos Group has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos Group$117.61M8.14$41.08M$0.0550.00Alpha Teknova$38.92M5.99-$26.75M-$0.42-10.38 Is CRON or TKNO more profitable? Cronos Group has a net margin of 14.19% compared to Alpha Teknova's net margin of -55.24%. Cronos Group's return on equity of -3.78% beat Alpha Teknova's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group14.19% -3.78% -3.62% Alpha Teknova -55.24%-26.51%-18.40% Which has more volatility and risk, CRON or TKNO? Cronos Group has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. Does the media favor CRON or TKNO? In the previous week, Cronos Group had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for Cronos Group and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.24 beat Cronos Group's score of 0.68 indicating that Alpha Teknova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CRON or TKNO? Alpha Teknova has a consensus target price of $10.00, suggesting a potential upside of 129.36%. Given Alpha Teknova's stronger consensus rating and higher possible upside, analysts clearly believe Alpha Teknova is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Alpha Teknova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Do insiders and institutionals have more ownership in CRON or TKNO? 8.7% of Cronos Group shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 7.3% of Cronos Group shares are held by insiders. Comparatively, 12.5% of Alpha Teknova shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryCronos Group beats Alpha Teknova on 10 of the 17 factors compared between the two stocks. Get Alpha Teknova News Delivered to You Automatically Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TKNO vs. The Competition Export to ExcelMetricAlpha TeknovaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$233.33M$3.16B$5.78B$9.92BDividend YieldN/A2.28%6.67%4.52%P/E Ratio-10.3821.1175.6726.67Price / Sales5.99463.83554.40206.13Price / CashN/A45.1137.1158.92Price / Book2.819.8611.446.09Net Income-$26.75M-$53.47M$3.28B$266.14M7 Day Performance0.93%2.79%0.78%0.22%1 Month Performance1.40%8.49%7.07%4.08%1 Year Performance-4.80%13.61%59.61%23.89% Alpha Teknova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TKNOAlpha Teknova2.9871 of 5 stars$4.36+2.8%$10.00+129.4%-4.5%$233.33M$38.92M-10.38240Positive NewsCRONCronos Group1.717 of 5 stars$2.60-0.2%N/A+14.2%$995.90M$117.61M51.90450NUVBNuvation Bio2.5235 of 5 stars$2.88-0.7%$7.33+154.6%+13.8%$992.59M$7.87M-4.5760News CoverageVERVVerve Therapeutics2.1671 of 5 stars$11.13flat$14.57+30.9%N/A$992.13M$32.33M-5.27110VALNValneva2.1869 of 5 stars$9.43-19.0%$16.00+69.7%+22.8%$990.49M$183.52M-9.62700Short Interest ↑Gap DownHigh Trading VolumeMLYSMineralys Therapeutics0.9932 of 5 stars$14.74-1.0%$32.25+118.8%+180.2%$986.80MN/A-4.1428News CoverageAnalyst ForecastATAIatai Life Sciences3.5251 of 5 stars$4.74+3.7%$11.25+137.3%+273.8%$979.53M$310K-6.8780Gap UpHigh Trading VolumeIOVAIovance Biotherapeutics4.4338 of 5 stars$2.53-5.9%$11.90+370.4%-79.0%$973.39M$164.07M-2.06500Positive NewsUPBUpstream Bio2.5144 of 5 stars$16.73-5.1%$56.50+237.7%N/A$950.42M$2.37M0.0038Positive NewsORICOric Pharmaceuticals4.7075 of 5 stars$9.62-1.2%$17.63+83.2%+12.3%$945.98MN/A-5.0980News CoveragePositive NewsAnalyst ForecastPHARPharming Group2.9398 of 5 stars$14.28+4.2%$30.00+110.1%+99.3%$938.65M$297.20M-109.85280News CoverageShort Interest ↓Gap Up Related Companies and Tools Related Companies CRON Competitors NUVB Competitors VERV Competitors VALN Competitors MLYS Competitors ATAI Competitors IOVA Competitors UPB Competitors ORIC Competitors PHAR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TKNO) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
